Status: current, Defined. Date: 30-Sep 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1686861000168110 | Go Kit (bisacodyl 5 mg) enteric tablet [3 tablets] (&) (citric acid 14 g + magnesium carbonate hydrate 7.5 g) powder for oral liquid [1 x 21.5 g sachet], 1 pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1686871000168116 | Go Kit (3 x Bisacodyl (Fresenius Kabi) enteric tablets, 1 x Magnesium Citrate 7.5/14 (Fresenius Kabi) sachet), 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Go Kit (3 x Bisacodyl (Fresenius Kabi) enteric tablets, 1 x Magnesium Citrate 7.5/14 (Fresenius Kabi) sachet), 1 pack | has container type | pack | true | Inferred relationship | Some | ||
| Go Kit (3 x Bisacodyl (Fresenius Kabi) enteric tablets, 1 x Magnesium Citrate 7.5/14 (Fresenius Kabi) sachet), 1 pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Go Kit (3 x Bisacodyl (Fresenius Kabi) enteric tablets, 1 x Magnesium Citrate 7.5/14 (Fresenius Kabi) sachet), 1 pack | Is a | containered trade product pack | false | Inferred relationship | Some | ||
| Go Kit (3 x Bisacodyl (Fresenius Kabi) enteric tablets, 1 x Magnesium Citrate 7.5/14 (Fresenius Kabi) sachet), 1 pack | Is a | Go Kit (3 x Bisacodyl (Fresenius Kabi) enteric tablets, 1 x Magnesium Citrate 7.5/14 (Fresenius Kabi) sachet), 1 pack | true | Inferred relationship | Some | ||
| Go Kit (3 x Bisacodyl (Fresenius Kabi) enteric tablets, 1 x Magnesium Citrate 7.5/14 (Fresenius Kabi) sachet), 1 pack | has TPUU | Magnesium Citrate 7.5/14 (Fresenius Kabi) powder for oral liquid, 21.5 g sachet | true | Inferred relationship | Some | 2 | |
| Go Kit (3 x Bisacodyl (Fresenius Kabi) enteric tablets, 1 x Magnesium Citrate 7.5/14 (Fresenius Kabi) sachet), 1 pack | has TPUU | Bisacodyl (Fresenius Kabi) 5 mg enteric tablet | true | Inferred relationship | Some | 1 | |
| Go Kit (3 x Bisacodyl (Fresenius Kabi) enteric tablets, 1 x Magnesium Citrate 7.5/14 (Fresenius Kabi) sachet), 1 pack | has container type | composite pack | false | Inferred relationship | Some | ||
| Go Kit (3 x Bisacodyl (Fresenius Kabi) enteric tablets, 1 x Magnesium Citrate 7.5/14 (Fresenius Kabi) sachet), 1 pack | has component pack | Bisacodyl (Fresenius Kabi) 5 mg enteric tablet, 3, blister pack | true | Inferred relationship | Some | ||
| Go Kit (3 x Bisacodyl (Fresenius Kabi) enteric tablets, 1 x Magnesium Citrate 7.5/14 (Fresenius Kabi) sachet), 1 pack | has component pack | Magnesium Citrate 7.5/14 (Fresenius Kabi) powder for oral liquid, 1 sachet | true | Inferred relationship | Some | ||
| Go Kit (3 x Bisacodyl (Fresenius Kabi) enteric tablets, 1 x Magnesium Citrate 7.5/14 (Fresenius Kabi) sachet), 1 pack | has TP | Go Kit | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR